Allergan Inc: Highlights

Financial data in U.S. dollars

Financial Highlights
Sales 4.50 Bil
Income 621.30 Mil
Net Profit Margin 13.85%
Return on Equity 14.00%
Debt/Equity Ratio 0.31
Revenue/Share 14.73
Earnings/Share 2.03
Book Value/Share 15.87
Dividend Rate 0.20
Payout Ratio 10.00%
Revenue - Quarterly Results (in Millions)
 FY (12/09)FY (12/08)FY (12/07)
1st Qtr1,007.21,076.6876.7
2nd Qtr1,130.81,172.0977.9
3rd Qtr1,141.31,098.2993.7
4th QtrNA1,056.61,090.6
Total3,279.34,403.43,938.9
Earnings Per Share - Quarterly Results
 FY (12/09)FY (12/08)FY (12/07)
1st Qtr$0.15$0.35$0.14
2nd Qtr$0.58$0.47$0.45
3rd Qtr$0.59$0.54$0.51
4th QtrNA$0.50$0.52
Total$1.32$1.86$1.62
Qtr. over Qtr. EPS Growth Rate
FY (12/09)FY (12/08)FY (12/07)
1st Qtr-70%-33%---
2nd Qtr287%34%221%
3rd Qtr2%15%13%
4th QtrNA-7%2%
Yr. over Yr. EPS Growth Rate
FY (12/09)FY (12/08)
1st Qtr-57%150%
2nd Qtr23%4%
3rd Qtr9%6%
4th QtrNA-4%

advertisement